Skip to main content
. Author manuscript; available in PMC: 2010 Jun 2.
Published in final edited form as: Mol Med Rep. 2008 Jul;1(4):589–594.

Table III.

Evaluation of diagnostic values of different TAA panels in the diagnosis of ovarian cancer.

No. of different TAA panelsa Positive no. and (%) of ovarian cancer Positive no. and (%) of NHS Sensitivity/specificity Positive PV/negative PV False positive/false negative
1 7 (21.9) 2 (2.4) 21.9/97.6 77.8/76.2 2.4/78.1
2 12 (37.5) 4 (4.9) 37.5/95.1 75.0/79.6 4.9/62.5
3 15 (46.9) 5 (6.1) 46.9/93.9 75.0/81.9 6.1/53.1
4 16 (50.0) 7 (8.5) 50.0/91.5 69.6/82.4 8.5/50.0
5 18 (56.3) 8 (9.8) 56.3/90.2 69.2/84.1 9.8/43.8
6 19 (59.4) 8 (9.8) 59.4/90.2 70.4/85.1 9.8/40.6
7 20 (62.5) 8 (9.8) 62.5/90.2 71.4/86.0 9.8/37.5
8 20 (62.5) 9 (11.0) 62.5/89.0 69.0/85.9 11.0/37.5
9 20 (62.5) 11 (13.4) 62.5/86.6 64.5/85.5 13.4/37.5
10 20 (62.5) 12 (14.6) 62.5/85.4 62.5/85.4 14.6/37.5
11 20 (62.5) 12 (14.6) 62.5/85.4 62.5/85.4 14.6/37.5
12 20 (62.5) 12 (14.6) 62.5/85.4 62.5/85.4 14.6/37.5
13 20 (62.5) 12 (14.6) 62.5/85.4 62.5/85.4 14.6/37.5
a

No. of different TAA panels, corresponding to the no. shown in Table II. Positive PV, positive predictive value; negative PV, negative predictive value.